Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
National Institute for Health and Care Excellence
Pharma
NICE to phase rollout for Lilly's tirzepatide in obesity
Roughly 220,000 people in England will be eligible for the drug during the three-year launch phase.
Zoey Becker
Dec 4, 2024 7:01pm
NICE rejects Vertex, CRISPR's Casgevy, asks for more data
Mar 14, 2024 11:24am
NICE rejects cost effectiveness of Vertex's cystic fibrosis meds
Nov 6, 2023 2:42pm
Lilly's Mounjaro bags key coverage recommendation in England
Sep 8, 2023 8:17am
Grifols opens plant, snags NICE nod for Tavlesse
Oct 19, 2022 10:15am
